Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • CLC bio
    Registered Vendor
    • Jan 2010
    • 24

    Korean "Hanwoo" bovine genome and whole SNPs announced

    Suwon, the Republic of Korea -- January 28, 2010 -- Today Korean scientists announced the completion of the de novo assembly and analysis of the genome of the native Korean bovine, called Hanwoo. The analysis also includes SNPs (single nucleotide polymorphisms), which shed light on both the genetic differences between cattle races and the systemic breeding of the Hanwoo.

    The Hanwoo is the third bovine genome to be finished in the world and it covers 92% of the reference genome sequence. The Korean scientists state that a comparison of the Hanwoo with the reference bovine genome stored in the NCBI database reveals key secrets about Hanwoo-specific development, diseases and evolution.

    "The Hanwoo genome has 72% novel SNP candidates and 28% identical polymorphisms compared to NCBI’s dbSNP" said Dr. Jong-Joo Kim, professor at Yeungnam University.

    This project has been a collaboration between Yeungnam University, Chungbuk National University, and Insilicogen. Next Generation Sequencing (NGS) technologies were used to sequence the genome. Assembly of the high-throughput sequencing data played an important role in ensuring that the analysis could be finished on schedule. The complete analysis software was provided by CLC bio, Aarhus, Denmark.

    "CLC bio's software, CLC NGS Cell and CLC Genomics Workbench, gave us a remarkable productivity so that the overall analyses for more than 628 million reads and 49 Giga base-pairs could be completed within a month on a standard computer" said Dr. Jun-Hyung Park, a manager of Insilicogen, Inc., Suwon, the Republic of Korea.

    The draft genome and the SNPs from this project will be published in both a scientific journal and online. The knowledge obtained will be applied, among others, in disease control, breeding of economic phenotypes, and diagnosis of bovine breeds.

    About Insilicogen

    바이오 빅데이터의 리더 (Read Data, Lead Big)


    Contact Insilicogen

    Nam-woo Choi, CEO/President
    Phone: +82-31-278-0061
    Mobile: +82-11-276-6559
    Email: [email protected]

    About CLC bio



    Contact CLC bio

    Thomas Knudsen, CEO
    Phone: +45 70 22 55 09
    E-mail: [email protected]

Latest Articles

Collapse

  • mylaser
    Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by mylaser
    Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
    The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
    Whether you're exploring Kheloyaar for the first time or want to understand...
    Yesterday, 09:27 PM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    Yesterday, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:04 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
7 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-02-2026, 11:08 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Working...